These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20544774)

  • 1. Towards dynamic drug design: identification and optimization of beta-galactosidase inhibitors from a dynamic hemithioacetal system.
    Caraballo R; Sakulsombat M; Ramström O
    Chembiochem; 2010 Jul; 11(11):1600-6. PubMed ID: 20544774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct STD NMR identification of beta-galactosidase inhibitors from a virtual dynamic hemithioacetal system.
    Caraballo R; Dong H; Ribeiro JP; Jiménez-Barbero J; Ramström O
    Angew Chem Int Ed Engl; 2010; 49(3):589-93. PubMed ID: 20013972
    [No Abstract]   [Full Text] [Related]  

  • 3. Discovery of new β-D-galactosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening.
    Abdula AM; Khalaf RA; Mubarak MS; Taha MO
    J Comput Chem; 2011 Feb; 32(3):463-82. PubMed ID: 20730780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatic thioglycoside inhibitors against the virulence factor LecA from Pseudomonas aeruginosa.
    Rodrigue J; Ganne G; Blanchard B; Saucier C; Giguère D; Shiao TC; Varrot A; Imberty A; Roy R
    Org Biomol Chem; 2013 Sep; 11(40):6906-18. PubMed ID: 24057051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Thio-beta-D-galactofuranosides: synthesis and evaluation as beta-D-galactofuranosidase inhibitors.
    Marino C; Mariño K; Miletti L; Manso Alves MJ; Colli W; de Lederkremer RM
    Glycobiology; 1998 Sep; 8(9):901-4. PubMed ID: 9675223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of naphthalimide group-bearing thioglycosides as novel β-N-acetylhexosaminidases inhibitors.
    Shen S; Chen W; Dong L; Yang Q; Lu H; Zhang J
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):445-452. PubMed ID: 29390898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Repression of beta-galactosidase synthesis by isopropyl thiogalactoside by the induction of antisense RNAs].
    Iarchuk OB; Troianovskaia IN; Matvienko NI
    Dokl Akad Nauk SSSR; 1986; 290(6):1499-502. PubMed ID: 2433114
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformationally-locked C-glycosides: tuning aglycone interactions for optimal chaperone behaviour in Gaucher fibroblasts.
    Navo CD; Corzana F; Sánchez-Fernández EM; Busto JH; Avenoza A; Zurbano MM; Nanba E; Higaki K; Ortiz Mellet C; García Fernández JM; Peregrina JM
    Org Biomol Chem; 2016 Jan; 14(4):1473-84. PubMed ID: 26690983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 1,5-dideoxy-1,5-iminoribitol C-glycosides through a nitrone-olefin cycloaddition domino strategy: identification of pharmacological chaperones of mutant human lysosomal β-galactosidase.
    Siriwardena A; Sonawane DP; Bande OP; Markad PR; Yonekawa S; Tropak MB; Ghosh S; Chopade BA; Mahuran DJ; Dhavale DD
    J Org Chem; 2014 May; 79(10):4398-404. PubMed ID: 24735108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioglycoligase-based assembly of thiodisaccharides: screening as beta-galactosidase inhibitors.
    Kim YW; Chen HM; Kim JH; Müllegger J; Mahuran D; Withers SG
    Chembiochem; 2007 Sep; 8(13):1495-9. PubMed ID: 17661304
    [No Abstract]   [Full Text] [Related]  

  • 13. The first synthesis of substituted azepanes mimicking monosaccharides: a new class of potent glycosidase inhibitors.
    Li H; Blériot Y; Chantereau C; Mallet JM; Sollogoub M; Zhang Y; Rodríguez-García E; Vogel P; Jiménez-Barbero J; Sinaÿ P
    Org Biomol Chem; 2004 May; 2(10):1492-9. PubMed ID: 15136805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
    Zhou Z; Bates M; Madura JD
    Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and glycosidase inhibitory activity of some N-substituted 5a-carba-beta-fuco- and beta-galactopyranosylamines, and selected derivatives.
    Ogawa S; Fujieda S; Sakata Y; Ishizaki M; Hisamatsu S; Okazaki K; Ooki Y; Mori M; Itoh M; Korenaga T
    Bioorg Med Chem; 2004 Dec; 12(24):6569-79. PubMed ID: 15556773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of D- and L-1-deoxyazasugars.
    Kato A; Kato N; Kano E; Adachi I; Ikeda K; Yu L; Okamoto T; Banba Y; Ouchi H; Takahata H; Asano N
    J Med Chem; 2005 Mar; 48(6):2036-44. PubMed ID: 15771446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
    Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
    Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli β-galactosidase inhibitors through modifications at the aglyconic moiety: experimental evidence of conformational distortion in the molecular recognition process.
    Calle L; Roldós V; Cañada FJ; Uhrig ML; Cagnoni AJ; Manzano VE; Varela O; Jiménez-Barbero J
    Chemistry; 2013 Mar; 19(13):4262-70. PubMed ID: 23424005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity of new dihydropyridine thioglycosides and their corresponding dehydrogenated forms.
    Abbas HA; El Sayed WA; Fathy NM
    Eur J Med Chem; 2010 Mar; 45(3):973-82. PubMed ID: 20004044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.